Treatment of Inflammation Around Implants With a Laser or an Ultrasonic Device
Peri-implant Mucositis
About this trial
This is an interventional treatment trial for Peri-implant Mucositis focused on measuring Clinical study, Bleeding on probing, Pus, Er:Yag laser, Ultrasonic device
Eligibility Criteria
Inclusion Criteria: ≥ 1 peri-implant site with probing depth ≥ 4 mm combined with bleeding and or pus on probing bone loss ≤ 2 mm measured from the implant shoulder (as a consequence of remodelling during the healing process) Exclusion Criteria: Subjects with uncontrolled diabetes HbA1c >6.5 Subjects requiring prophylactic antibiotics Subjects taking prednisolone Subjects taking medications known to have effects on gingival overgrowth
Sites / Locations
- University of Kristianstad
Arms of the Study
Arm 1
Arm 2
Experimental
Active Comparator
Er:Yag laser treatment
Ultrasonic device treatment
The experimental (test) group will receive the following treatment: The submucosal debridement will be performed with an Er:Yag laser (AdvErL EVO, Morita Corporation, Japan). The P-400 tip is placed into the peri-implant mucositis pockets mesially, lingually, distally and buccally while rinsing water. Careful attempts are to cover the full circumference of the implant.
The active comparator (control) group will receive the following treatment: The submucosal debridement will be performed by a piezoelectric ultrasonic device with a PEEK coated tip (EMS, Switzerland). The tip is placed into the peri-implant mucositis pockets mesially, lingually, distally and buccally while rinsing water. Careful attempts are to cover the full circumference of the implant.